← Eichor
Condition: Symptomatic Dermographism Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Symptomatic Dermographism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · 73 location(s) · Celldex Therapeutics · NCT07266402Deep Phenotyping of CIndU
Phase N/A · 3 location(s) · Centre for Human Drug Research, Netherlands · NCT07359430Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chron
Phase 2 · 17 location(s) · Novartis Pharmaceuticals · NCT06865651A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
Phase 1 · 2 location(s) · Granular Therapeutics Limited · NCT07181369
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.